Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Boeve, Bradley F ^a  

^a Mayo Clinic   (United States)

Author keywords

Alzheimer's disease; Dementia; Dementia with Lewy bodies; Lewy body disease; Mild cognitive impairment; Neuropathology; Neuropsychology

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PROTEIN; BIOLOGICAL MARKER; FLORBETAPIR F 18; FLUORODEOXYGLUCOSE; FLUTEMETAMOL F 18; IOFLUPANE I 123; TAU PROTEIN;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN SCINTISCANNING; COGNITIVE DEFECT; COMORBIDITY; DAILY LIFE ACTIVITY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DOPAMINE TRANSPORTER SCANNING; HUMAN; LANGUAGE DISABILITY; MEMORY DISORDER; METABOLIC DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PARKINSON DISEASE; PARKINSONISM; PERCEPTION DISORDER; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL HALLUCINATION;

EID: 84858694031     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70015-3     Document Type: Article

References (18)

1. McKhann G, Knopman D, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-9.
2. Jack CJ, Knopman D, Jagust W, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-28.
3. Walker Z, Jaros E, Walker R, Lee L, Costa D, Livingston G, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neuro Neurosurg Psychiatry 2007;78:1176-81.
4. McKeith I, Dickson D, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Dementia with Lewy bodies: Diagnosis and management: Third report of the DLB Consortium. Neurology 2005;65:1863-72.
5. Fujishiro H, Ferman T, Boeve B, Smith GE, Graff-Radford NR, Uitti RJ, et al. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008;67:649-56.
6. Ferman T, Boeve B, Smith G, Lin SC, Silber MH, Pedraza O, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 2011;77:875-82.
7. Ferman TJ, Boeve BF. Dementia with Lewy bodies. Neurol Clin 2007;25(3): 741-60.
8. Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-8.
9. Petersen R. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256:183-94.
10. Albert M, Dekosky S, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-9.
11. Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, et al. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: A clinicopathological study. Brain 2009;133:540-56.
12. Savica R, Rocca W, Ahlskog J. When does Parkinson disease start? Arch Neurol 2010;67:798-801.
13. Boeve B. REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann NY Acad Sci 2010;1184:17-56.
14. Postuma R, Lang A, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006; 66:845-51.
15. Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2010;9(11):1070-7.
16. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-7.
17. Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord 2010;16:177-80.
18. Poletti M, Emre M, Bonuccelli U. Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism Relat Disord 2011;17:579-86.